Audit of the Spanish EURECCA Esophagogastric Cancer Registry

Objective. The objective of the study is to verify and validate the data collected in the Spanish EURECCA (EUropean REgistry of Cancer CAre) Esophagogastric Cancer Registry between January 2014 and December 2017 through an audit process. It is also intended to describe the initiation and implementation of this Registry as well as its early outcomes. Methods. An audit of registered cases (esophageal, esophagogastric junction and gastric cancer resectable patients undergoing surgery) from 01/01/2014 to 12/31/2017 and a descriptive analysis of these data will be performed. Expected results. The study could show that the Spanish EURECCA Esophagogastric Cancer Registry is a reliable source of information, valid for carrying out specific and exhaustive analysis that may lead to high quality publications in indexed journals. It is also expected to generate a high impact based on the large number of cases included in the Registry, favoring new research projects. Relevance. The standardization of the data collection is essential to compare outcomes between different centers, regions and countries. This study will allows us to verify the integrity of the collected data as well as its accuracy, a critical aspect to gain credibility for future studies using the Registry data.

Sex

All

Inclusion Criteria:

* patients diagnosed with esophageal, esophagogastric and gastric cancer candidates for radical resection

Exclusion Criteria:

* metastatic patients
* patients candidates for palliative treatment
* patients without a signed informed consent

• BACKGROUNDde Steur WO, Henneman D, Allum WH, Dikken JL, van Sandick JW, Reynolds J, Mariette C, Jensen L, Johansson J, Kolodziejczyk P, Hardwick RH, van de Velde CJ; EURECCA Upper GI Group. Common data items in seven European oesophagogastric cancer surgery registries: towards a European upper GI cancer audit (EURECCA Upper GI). Eur J Surg Oncol. 2014 Mar;40(3):325-9. doi: 10.1016/j.ejso.2013.11.021. Epub 2013 Dec 13. PMID 24412054
• BACKGROUNDMessager M, de Steur WO, van Sandick JW, Reynolds J, Pera M, Mariette C, Hardwick RH, Bastiaannet E, Boelens PG, van deVelde CJ, Allum WH; EURECCA Upper GI Group. Variations among 5 European countries for curative treatment of resectable oesophageal and gastric cancer: A survey from the EURECCA Upper GI Group (EUropean REgistration of Cancer CAre). Eur J Surg Oncol. 2016 Jan;42(1):116-22. doi: 10.1016/j.ejso.2015.09.017. Epub 2015 Sep 30. PMID 26461256
• BACKGROUNDMessager M, de Steur W, Boelens PG, Jensen LS, Mariette C, Reynolds JV, Osorio J, Pera M, Johansson J, Kolodziejczyk P, Roviello F, De Manzoni G, Monig SP, Allum WH; EURECCA Upper GI group (European Registration of Cancer Care). Description and analysis of clinical pathways for oesophago-gastric adenocarcinoma, in 10 European countries (the EURECCA upper gastro intestinal group - European Registration of Cancer Care). Eur J Surg Oncol. 2016 Sep;42(9):1432-47. doi: 10.1016/j.ejso.2016.01.001. Epub 2016 Feb 6. PMID 26898839
• BACKGROUNDJensen LS, Nielsen H, Mortensen PB, Pilegaard HK, Johnsen SP. Enforcing centralization for gastric cancer in Denmark. Eur J Surg Oncol. 2010 Sep;36 Suppl 1:S50-4. doi: 10.1016/j.ejso.2010.06.025. Epub 2010 Jul 2. PMID 20598495
• BACKGROUNDKjaer DW, Larsson H, Svendsen LB, Jensen LS. Changes in treatment and outcome of oesophageal cancer in Denmark between 2004 and 2013. Br J Surg. 2017 Sep;104(10):1338-1345. doi: 10.1002/bjs.10586. Epub 2017 Jul 18. PMID 28718940
• BACKGROUNDLinder G, Lindblad M, Djerf P, Elbe P, Johansson J, Lundell L, Hedberg J. Validation of data quality in the Swedish National Register for Oesophageal and Gastric Cancer. Br J Surg. 2016 Sep;103(10):1326-35. doi: 10.1002/bjs.10234. Epub 2016 Jul 28.